A. Luraschi

发表

Combined differentiating therapy for myelodysplastic syndromes: a phase II study.

A. Pileri, D. Ferrero, G. Vietti-Ramus, 1996, Leukemia research.

Melphalan, prednisone, and lenalidomide for newly diagnosed myeloma: kinetics of neutropenia and thrombocytopenia and time-to-event results.

M. Boccadoro, A. Larocca, F. Gay, 2009, Clinical lymphoma & myeloma.

The VAD-DCEP sequence is an effective pre-transplant therapy in untreated multiple myeloma.

R. Cairoli, C. Klersy, E. Morra, 2004, Haematologica.

Management of Neoplastic Pericardial Effusions

S. Cozzi, P. Buscaglia, A. Gioria, 2010, Tumori.

Management of Neoplastic Pericardial Effusions

S. Cozzi, P. Buscaglia, A. Gioria, 2010 .

Fludarabine, Cyclophosphamide and Rituximab in Waldenström’s Macroglobulinemia: An Effective Regimen Requiring a New Category of Response Criteria and a Delayed Assessment of Results

F. Ferrara, F. Ricci, A. Tedeschi, 2007 .

DCEP (dexamethasone, cyclophosphamide, etoposide, and cisplatin) is an effective regimen for peripheral blood stem cell collection in multiple myeloma

R. Cairoli, E. Morra, F. Rodeghiero, 2001, Bone Marrow Transplantation.

[Determination of lymphocyte subpopulations, defined with monoclonal antibodies, in patients with iron deficiency anemia].

A. Gioria, A. Luraschi, P. Fedeli, 1991, Minerva medica.

[Primary extranodal non-Hodgkin's lymphoma of muscle tissue].

G. Saglietti, G. Ripamonti, M. Bersi, 1997, Recenti progressi in medicina.

[Systemic mastocytosis without skin involvement. Presentation of a case and review of the literature].

A. Luraschi, P. Fedeli, A. M. Foscolo, 1985, Minerva medica.

Oral RevlimidR Plus Melphalan and Prednisone (R-MP) for Newly Diagnosed Multiple Myeloma.

M. Boccadoro, S. Bringhen, G. Rossi, 2005 .